EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY NUMBER OF ADDITIONAL ASTHMA CONTROLLER MEDICATIONS: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY

被引：1
|
作者：
Kraft, Monica
Colice, Gene L.
Ambrose, Christopher
Cook, William
Hunter, Gillian
Molfino, Eleonora A.
Martin, Neil
Roseti, Stephanie L.
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.012
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：11A / 12A
页数：2
相关论文
共 50 条
  • [41] Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)
    Pavord, Ian D.
    Hoyte, Flavia C. L.
    Lindsley, Andrew W.
    Ambrose, Christopher S.
    Spahn, Joseph D.
    Roseti, Stephanie L.
    Cook, Bill
    Grif, Janet M.
    Hellqvist, Asa
    Martin, Nicole
    Llanos, Jean-Pierre
    Martin, Neil
    Colice, Gene
    Corren, Jonathan
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : 587 - 597.e3
  • [42] Efficacy of Tezepelumab in Patients with Moderate-to-Severe Uncontrolled Asthma: A Pooled Analysis of the Phase 2b PATHWAY and Phase 3 NAVIGATOR Studies
    Corren, J.
    Menzies-Gow, A.
    Ambrose, C.
    Cook, W.
    Hellquist, A.
    Roseti, S.
    Molfinao, N.
    Lanos-Ackert, P. J.
    Colice, G.
    PNEUMOLOGIE, 2022, 76 : S14 - S14
  • [43] Effect of tezepelumab on the proportion of exacerbation-free patients with severe, uncontrolled asthma in NAVIGATOR
    Korn, Stephanie
    Bourdin, Arnaud
    Chupp, Geoffrey
    Colice, Gene
    Ambrose, Christopher S.
    Kmita, Kamil
    Llanos-Ackert, Jean-Pierre
    Molfino, Nestor
    Cook, Bill
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [44] Efficacy of Tezepelumab in Patients with Moderate-to-Severe, Uncontrolled Asthma: A Pooled Analysis of the Phase 2b PATHWAY and Phase 3 NAVIGATOR Studies
    Ambrose, Chris
    Menzies-Gow, Andrew
    Cook, Bill
    Hellqvist, Asa
    Roseti, Stephanie
    Molfino, Nestor
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    Corren, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB16 - AB16
  • [45] Tezepelumab Efficacy By SNOT-22 Score In Patients With Severe, Uncontrolled Asthma And Comorbid Nasal Polyps In NAVIGATOR
    Jacobs, Joshua
    Hoyte, Flavia
    Spahn, Joseph
    Ambrose, Chris
    Martin, Nicole
    Vong, Sylvia
    Caveney, Scott
    Cook, Bill
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB17 - AB17
  • [46] Effect Of Tezepelumab On Rescue Medication Use And Night-Time Awakenings In Patients With Severe, Uncontrolled Asthma: Results From The NAVIGATOR Study
    Carr, Warner
    Ambrose, Chris
    Hunter, Gillian
    Ponnarambil, Sandhia
    Llanos-Ackert, Jean-Pierre
    Clarke, Nicole
    Cook, Bill
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB14 - AB14
  • [47] The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
    Corren, J.
    Menzies-Gow, A.
    Ambrose, C. S.
    Cook, B.
    Kmita, K.
    Colice, G.
    Llanos-Ackert, J.
    ALLERGY, 2021, 76 : 13 - 14
  • [48] Effect of tezepelumab on seasonal exacerbations in patients with severe, uncontrolled asthma grouped by blood eosinophil count
    Corren, J.
    Menzies-Gow, A.
    Ambrose, C. S.
    Colice, G.
    Roseti, S. L.
    Hellqvist, A.
    Kmita, K.
    Lindsley, A. W.
    Cook, B.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [49] Clinically Meaningful Improvements in St George's Respiratory Questionnaire Score with Tezepelumab Versus Placebo in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Kraft, M.
    Corren, J.
    Ambrose, C. S.
    Cook, B.
    Clarke, N.
    Hunter, G.
    Molfino, N.
    Ponnarambil, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [50] Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR (vol 16, pg 915, 2023)
    Laidlaw, Tm
    Menzies-Gow, A.
    Caveney, S.
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 1053 - 1053
12345